Intrinsiqq

Naturhouse Health, S.A. (NTH.XMAD) Quality Score

NTH.XMAD
Quality81

Business quality remains strong (avg 95/100), but growth is pulling the composite down (avg 50/100).

Broad-market heuristics · Not a buy/sell signal

Valuation and growth

Earnings Multiple
90/100
13.3x

Under 20x, reasonable relative to earnings

Cash Flow Multiple
90/100
11.5x

Under 20x cash flow, well covered

Revenue Growth
0/100
-3.1%

Below 2%, essentially flat

Cash Flow Growth
100/100
23.9%

Above 10% CAGR, strong compounder

Business Quality & Capital Allocation

Share Dilution
80/100
0.0%

Roughly flat, no meaningful dilution

Margin Trend
100/100
+3.3pp

Expanded 3+pp, strong improvement

Capital Structure
100/100
-€12M

Net cash position, no leverage concern

2022
€15M
€3M
2023
€27M
€3M
2024
€22M
€3M
2025
€14M
€2M
Return on Capital
100/100
35.5%

Above 20%, exceptional capital efficiency

Customize WeightsPremiumUpgrade

Naturhouse Health (NTH.XMAD) quality: score, margins and returns

Naturhouse Health (NTH.XMAD) scores 81/100 on Intrinsiqq's quality score (a high-quality business), a weighted blend of 8 metrics each scored 0 to 100, on 27.8% operating margins and 35.5% ROIC. Every metric is computed from company filings; this is analysis, not investment advice.

Frequently asked

Is Naturhouse Health (NTH.XMAD) a high-quality business?+

Naturhouse Health scores 81 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which rates it a high-quality business on these measures. Recent figures include a 27.8% operating margin and a 35.5% return on invested capital. Quality and price are separate questions: even a great business can be a poor investment if you overpay, so read this score alongside the valuation. The metric-by-metric breakdown is on this scorecard.

What does Naturhouse Health's quality score measure?+

Intrinsiqq's quality score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, change in share count, and balance-sheet strength, each computed from NTH.XMAD's company filings rather than opinion or sentiment. A higher score means a more durable, capital-efficient business; it is not a buy or sell signal. Open each metric on this page to see exactly where Naturhouse Health scores well and where it falls behind.

What is Naturhouse Health's return on invested capital (ROIC)?+

Naturhouse Health earns about 35.5% on its invested capital, which is exceptional. ROIC measures how much profit a company generates per dollar put to work; sustained ROIC above its cost of capital is one of the clearest signs of a real competitive moat. Compare it to NTH.XMAD's margins and growth on this scorecard to judge durability.

How profitable is Naturhouse Health?+

Naturhouse Health runs an operating margin of about 27.8% and a net margin of about 21.2%. Revenue has grown at roughly -4.6% a year recently. High, stable margins usually point to pricing power and operating discipline. Margins are most telling next to growth and returns on capital, all of which feed this quality score. This is analysis from company filings, not investment advice.

How the market compares: US profitability statistics

Related stocks: Packaged Foods

Spot a number that looks wrong?

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.